Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.06.02
关于控股子公司收到药物临床试验补充申请批准通知书的公告
2021.05.27
2020年年度股东大会决议公告
2021.05.27
2020年年度股东大会法律意见书
2021.05.20
深圳市大地妈妈药业集团股份有限公司公开发行公司债券2021年跟踪评级报告
2021.05.19
关于孙暄先生增持公司H股计划的进展公告
2021.05.07
关于董事辞职及计划增持公司H股的公告
2021.04.29
深圳市高新投集团有限公司2020年年度财务报表（未经审计）
2021.04.28
关于控股子公司品种临床试验申请获得受理的公告
2021.04.23
关于2020年年度股东大会增加临时提案暨股东大会补充通知的公告
2021.04.23
H股公告
第一页
上一页
24
25
26
27
28
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
